Cassava Sciences, Inc
Cassava Sciences, Inc., a clinical-stage drug development company, develops drugs for nervous system disorders. The company's lead therapeutic product candidate PTI-125, a small molecule drug that is in Phase II clinical trial for the treatment of Alzheimer's disease. It is also developing PTI-125Dx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas. Show More...
-
Website http://www.cassavasciences.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 2.01 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.96 -0.42 -0.56 4.9 -1.89 -2.17 -2.28 -1.82 -0.61 -0.27 -0.24 Dividends USD Payout Ratio % * Shares Mil 6.0 6.0 6.0 6.0 6.0 6.0 7.0 7.0 11.0 17.0 19.0 Book Value Per Share * USD 5.37 6.8 2.03 2.19 6.3 5.06 3.08 1.72 1.16 0.8 1.0 Free Cash Flow Per Share * USD -0.02 -0.45 -1.12 -1.14 -1.31 -1.28 -1.95 -1.5 -0.7 -0.14 Return on Assets % -8.55 -2.64 -4.42 58.98 -27.22 -38.85 -57.99 -79.06 -42.34 -21.23 -19.44 Financial Leverage (Average) 3.01 2.23 4.33 1.04 1.02 1.09 1.04 1.12 1.03 1.06 1.05 Return on Equity % -17.03 -6.76 -11.98 102.69 -28.04 -40.75 -61.87 -84.07 -44.72 -22.2 -20.38 Return on Invested Capital % -19.41 -9.09 -13.55 102.46 -28.14 -40.91 -62.32 -84.34 -45.43 -23.67 -21.73 Interest Coverage Current Ratio 7.0 7.42 5.65 27.82 48.03 12.42 28.68 9.42 39.22 16.83 22.6 Quick Ratio 6.99 7.39 5.63 27.67 47.75 12.27 28.14 9.26 38.76 16.64 22.36 Debt/Equity